La lecture à portée de main
Découvre YouScribe en t'inscrivant gratuitement
Je m'inscrisDécouvre YouScribe en t'inscrivant gratuitement
Je m'inscrisDescription
Informations
Publié par | frost-sullivan |
Publié le | 12 novembre 2013 |
Nombre de lectures | 6 |
Langue | English |
Extrait
PR Newswire
MOUNTAIN VIEW, California, Nov. 12, 2013
-- Frost & Sullivan: Healthcare innovation hinges on managing escalating amounts of data priming to more than triple the market
The decreasing cost of genome sequencing lends momentum to the global next-generation sequencing (NGS) informatics market. As affordability drives adoption of genome sequencing in multiple end-user segments, an enormous output of NGS data to store and analyze is an overwhelming result. While primary and secondary data analysis tools are likely to become a commodity as pipelines standardize, the high-value tertiary data analysis segment used for biological interpretation and clinical reporting will drive revenue growth.